Catheter ablation of atrial fibrillation: The need for studies to assess the efficacy and safety of novel anticoagulants

Journal of Interventional Cardiac Electrophysiology

Volumn 36, Issue 1, 2013, Pages 3-4

  Naccarelli, Gerald V ^a   Gonzalez, Mario D ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; WARFARIN;

ANTICOAGULANT THERAPY; ARTERIOVENOUS FISTULA; BLEEDING; CARDIAC PATIENT; CATHETER ABLATION; COHORT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDITORIAL; FALSE ANEURYSM; GROIN HEMATOMA; HEART ATRIUM FIBRILLATION; HUMAN; PERICARDIAL EFFUSION; PRIORITY JOURNAL; THROMBOEMBOLISM; TREATMENT OUTCOME;

ANTICOAGULANTS; ANTITHROMBINS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; CATHETER ABLATION; HUMANS; MORPHOLINES; RISK FACTORS; THIOPHENES; THROMBOEMBOLISM; UNITED STATES; WARFARIN;

EID: 84873730325     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-012-9720-3     Document Type: Editorial

References (7)

1. Oral, H.; Chugh, A.; Ozaydin, M.; Good, E.; Fortino, J.; Sankaran, S.; Reich, S.; Igic, P.; Elmouchi, D.; Tschopp, D.; Wimmer, A.; Dey, S.; Crawford, T.; Pelosi, F.; Jr.; Jongnarangsin, K.; Bogun, F.; & Morady, F. (2006). Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation, 114, 759-765.
2. Wazni, O. M.; Beheiry, S.; Fahmy, T.; Barrett, C.; Hao, S.; Patel, D.; Di Biase, L.; Martin, D. O.; Kanj, M.; Arruda, M.; Cummings, J.; Schweikert, R.; Saliba, W.; & Natale, A. (2007). Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation, 116, 2531-2534.
3. Hussein, A. A.; Martin, D. O.; Saliba, W.; Patel, D.; Karim, S.; Batal, O.; Banna, M.; Williams-Andrews, M.; Sherman, M.; Kanj, M.; Bhargava, M.; Dresing, T.; Callahan, T.; Tchou, P.; Di Biase, L.; Beheiry, S.; Lindsay, B.; Natale, A.; & Wazni, O. (2009). Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm, 6, 1425-1429.
4. Page, S. P.; Siddiqui, M. S.; Finlay, M.; Hunter, R. J.; Abrams, D. J.; Dhinoja, M.; Earley, M. J.; Sporton, S. C.; & Schilling, R. J. (2011). Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance. Journal of Cardiovascular Electrophysiology, 22, 265-270.
5. Winkle, R. A.; Mead, R. H.; Engel, G.; Kong, M. H.; & Patrawala, R. A. (2012). The use of dabigatran immediately after atrial fibrillation ablation. Journal of Cardiovascular Electrophysiology, 23(3), 264-268.
6. Lakkireddy, D.; Reddy, Y. M.; Di Biase, L.; Vanga, S. R.; Santangeli, P.; Swarup, V.; Pimentel, R.; et al. (2012). Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. Journal of the American College of Cardiology, 59(13), 1168-1174.
7. Snipelisky, D.; Kauffman, C.; Prussak, K.; Johns, G.; Venkatachalam, K.; Kusumoto, F. (2012). A comparison of bleeding complications post ablation between dabigatran and warfarin. Journal of Interventional Cardiac Electrophysiology (in press).